ACHE and early-onset autosomal dominant Alzheimer disease: AChE inhibition is a validated therapeutic strategy, as reducing the degradation of acetylcholine enhances cholinergic neurotransmission, a key aspect in mitigating the symptoms of Alzheimer’s disease [42].